Cutting-Edge Science and Technology to Deliver New Therapeutic Applications

The Emerging Therapeutics & Technologies stream presents three emerging and fast-developing topics, that represent the latest trends and future outlook for many biologics developers. Emerging Indications for Therapeutic Antibodies will reveal new targets and novel mechanisms of actions for development of next-generation therapeutics beyond oncology. Gene Therapy: Advancing from Bench to Clinic will explore the exciting landscape of gene therapy, highlighting regulatory, commercialization and analytical strategies, and showcasing case studies of gene therapies in rare and neurological diseases.

Conferences Include:

August 31 - September 1

Emerging Indications for Therapeutic Antibodies

September 2-3

Gene Therapy

Keynote Speakers Include:

Madhusudan Natarajan, PhD, Head, Rare Diseases DDU, Takeda

Mike Singer, PhD, Medical Officer, Division of Clinical Evaluation and Pharmacology/Toxicology, Center for Biologics Evaluation and Research, FDA

2024 PROGRAMS

View By:

• Display of Biologics
• Engineering Antibodies
• Machine Learning for Protein Engineering

• Antibodies for Cancer Therapy
• Emerging Targets for Oncology
• Antibody Drug Conjugates

• TS: Intro to Bispecifics
• Advancing Bispecific Antibodies
• Engineering Bispecific Antibodies

• Advances in Immunotherapy
• Cell-Based Immunotherapy
• In vivo Cell and Gene Engineering

• Difficult-to-Express Proteins
• Optimizing Protein Expression
• Protein Production Workflows

• Digital Integration in Biotherapeutic Analytics
• Biophysical Methods
• Characterization for Novel Biotherapeutics

• TS: Intro to Immunogenicity
• Immunogenicity Assessment and Management
• TS: Intro to Bioassays

• Emerging Indications for Therapeutic Antibodies
• mRNA Therapeutics
• In vivo Cell and Gene Engineering